TickerFactsScreenerDevelopers

Silence Therapeutics plc (SLN) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2022: 107.81M2023: 118.85M2024: 141.67M2025: 141.70M141.70M
2022Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
2025141.70M+0.0%
2024141.67M+19.2%
2023118.85M+10.2%
2022107.81M—